4//SEC Filing
GRAYZEL DAVID S. 4
Accession 0000950170-24-037397
CIK 0001661998other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:39 PM ET
Size
5.9 KB
Accession
0000950170-24-037397
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
GRAYZEL DAVID S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+12,767→ 12,767 totalExercise: $16.82Exp: 2034-03-24→ Common Stock (12,767 underlying)
Footnotes (2)
- [F1]One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001732786
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:39 PM ET
- Size
- 5.9 KB